Newly FDA Approved Alzheimer’s Biomarkers Tes...

The current landscape of testing for NSCLC is complex, with many new biomarkers emerging rapidly, more points during which testing is possible, and precision drug treatments available on the basis of findings from biomarker testing. While promising for patients, the result of thi ...  Show more

Host David Ritter, MA is joined by Lotte Mulder, PhD and Kamran Mirza, MD, PhD, FASCP to discuss their new book, Mia the Marvelous Lab Explorer. The adventure follows Mia, a superhero and scientist, who uses laboratory science to explain why a friend has fallen ill with leukemia. ...  Show more

Laboratory tests provide doctors with crucial information for diagnosis, monitoring disease progression, evaluating organ function, assessing risk factors for diseases and more. Laboratory testing can be reassuring, however, it is often deemed unnecessary. In this short episode r ...  Show more

In this episode of OncoTalks, Dr. Paul Conkling and Dr. Kashif Ali explore how minimal residual disease (MRD) testing using circulating tumor DNA (ctDNA) is reshaping breast cancer management. They discuss how this innovative approach enables the detection of molecular disease ...

Join us for an insightful podcast exploring the latest milestones in the understanding and treatment of IgA nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS). Discover how recent breakthroughs in our understanding of these conditions are advancing clinical research ...  Show more

In this episode, Dr. Ashwin Parihar speaks with Dr. Petrice Cogswell about the radiologist's critical role in diagnosing Alzheimer's disease and how imaging advances are reshaping early detection. They also explore how innovation at scale, platform thinking, and operational al ...